Atlas Trials

Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder

Clinical trial NCT02267629 · COMPLETED

Trial details

NCT number
NCT02267629
Sponsor
New York State Psychiatric Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Obsessive-Compulsive Disorder (OCD)
Start date
2014-10-01
Primary completion
2016-02-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.